Wolverine Trading, LLC X4 Pharmaceuticals, Inc Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$0.58 - $1.47 $1,218 - $3,087	-2,100 Reduced 5.87%	33,700 $19,000
Q1 2024 May 15, 2024	BUY	$0.72 - $1.46 $5,616 - $11,388	7,800 Added 27.86%	35,800 $49,000
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $7,137 - $11,583	11,700 Added 71.78%	28,000 $23,000
Q3 2023 Nov 15, 2023	SELL	$1.03 - $2.02 $40,067 - $78,578	-38,900 Reduced 70.47%	16,300 $17,000
Q2 2023 Aug 23, 2023	BUY	$0.82 - $2.49 $45,264 - $137,448	55,200 New	55,200 $107,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $22,990 - $67,760	12,100 New	12,100 $27,000

105

100M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.